NFKB1 and Insulin resistance: Similarly, Celastrol's ability to inhibit NF-κB activity in a type 2 diabetic animal model serves yet another example of Celatrol's therapeutic role in transiently lowering blood glucose levels and inhibiting insulin resistance and diabetic nephropathy (40).